Full text is available at the source.
Abstract
Metformin may offer potential disease-modifying effects in chronic obstructive pulmonary disease (COPD).
- COPD is associated with accelerated biological aging and progressive lung function decline.
- Current therapies for COPD primarily improve symptoms and reduce exacerbations but do not significantly alter disease progression.
- Metformin has shown anti-aging properties by influencing pathways related to oxidative stress and inflammation.
- Metformin may modulate mitochondrial dysfunction and cellular aging processes, which are relevant in the context of COPD.
Simplified